Jawed Fareed

21.3k total citations · 1 hit paper
784 papers, 12.5k citations indexed

About

Jawed Fareed is a scholar working on Internal Medicine, Surgery and Hematology. According to data from OpenAlex, Jawed Fareed has authored 784 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 287 papers in Internal Medicine, 286 papers in Surgery and 268 papers in Hematology. Recurrent topics in Jawed Fareed's work include Venous Thromboembolism Diagnosis and Management (287 papers), Heparin-Induced Thrombocytopenia and Thrombosis (218 papers) and Blood Coagulation and Thrombosis Mechanisms (163 papers). Jawed Fareed is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (287 papers), Heparin-Induced Thrombocytopenia and Thrombosis (218 papers) and Blood Coagulation and Thrombosis Mechanisms (163 papers). Jawed Fareed collaborates with scholars based in United States, Germany and France. Jawed Fareed's co-authors include Jeanine M. Walenga, Debra Hoppensteadt, Walter Jeske, Debra A. Hoppensteadt, Omer Iqbal, Harry L. Messmore, Rodger L. Bick, Robert J. Linhardt, Bruce Lewis and J Choay and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Oncology.

In The Last Decade

Jawed Fareed

748 papers receiving 11.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia

2001 507 citations Bruce Lewis, Jawed Fareed et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Jawed Fareed	4.4k	4.1k	3.6k	3.1k	1.8k	784	12.5k
Alan D. Michelson	3.2k 0.7×	3.5k 0.8×	7.4k 2.0×	5.6k 1.8×	1.3k 0.7×	237	15.0k
Marie‐Christine Alessi	1.9k 0.4×	3.3k 0.8×	5.7k 1.6×	5.1k 1.6×	3.0k 1.7×	320	19.0k
Oswald Wagner	1.1k 0.3×	2.0k 0.5×	2.7k 0.7×	1.3k 0.4×	4.2k 2.3×	303	14.3k
Margareta Blombäck	1.5k 0.3×	1.7k 0.4×	2.6k 0.7×	5.7k 1.8×	1.3k 0.7×	280	12.8k
Debra Hoppensteadt	1.5k 0.3×	1.4k 0.3×	1.3k 0.4×	1.2k 0.4×	723 0.4×	380	5.0k
Meinrad Gawaz	2.8k 0.6×	5.8k 1.4×	11.6k 3.2×	6.4k 2.1×	5.5k 3.0×	607	26.7k
I. Juhan‐Vague	1.2k 0.3×	2.0k 0.5×	3.6k 1.0×	4.2k 1.4×	2.3k 1.3×	230	15.2k
Frank W. Sellke	1.1k 0.2×	5.9k 1.4×	7.1k 2.0×	720 0.2×	5.8k 3.2×	575	22.7k
Juan J. Badimón	1.8k 0.4×	8.3k 2.0×	8.7k 2.4×	3.0k 1.0×	3.4k 1.9×	305	21.3k
Paolo Gresele	1.0k 0.2×	1.7k 0.4×	2.5k 0.7×	3.8k 1.2×	1.3k 0.7×	311	10.1k

Countries citing papers authored by Jawed Fareed

Since Specialization

Citations

This map shows the geographic impact of Jawed Fareed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jawed Fareed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jawed Fareed more than expected).

Fields of papers citing papers by Jawed Fareed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jawed Fareed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jawed Fareed. The network helps show where Jawed Fareed may publish in the future.

Co-authorship network of co-authors of Jawed Fareed

This figure shows the co-authorship network connecting the top 25 collaborators of Jawed Fareed. A scholar is included among the top collaborators of Jawed Fareed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jawed Fareed. Jawed Fareed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fareed, Jawed, et al.. (2025). Treatment with Sulodexide Downregulates Biomarkers for Endothelial Dysfunction in Convalescent COVID-19 Patients. Clinical and Applied Thrombosis/Hemostasis. 31. 3005479151–3005479151. 1 indexed citations

Hoppensteadt, Debra, et al.. (2024). Thromboinflammatory Biomarkers of Cardiorenal Syndrome in Patients With End-Stage Renal Disease. Clinical and Applied Thrombosis/Hemostasis. 30. 3005444605–3005444605.

Fareed, Jawed, et al.. (2024). Charlson and Elixhauser Comorbidity Indices for Prediction of Mortality and Hospital Readmission in Patients With Acute Pulmonary Embolism. Clinical and Applied Thrombosis/Hemostasis. 30. 3005435348–3005435348.

Hoppensteadt, Debra, et al.. (2024). Vascular Endothelial Dysfunction and Immunothrombosis in the Pathogenesis of Atrial Fibrillation. Clinical and Applied Thrombosis/Hemostasis. 30. 3005477642–3005477642. 2 indexed citations

Bansal, Vinod, et al.. (2024). Endogenous Dysregulation of Thromboinflammatory Biomarkers in End-Stage Renal Disease, and Their Amplification by Heart Failure. Clinical and Applied Thrombosis/Hemostasis. 30. 3005445362–3005445362. 1 indexed citations

Darki, Amir, et al.. (2023). Glycemic Control and Plasma Levels of Pro-Inflammatory and Pro-Thrombotic Biomarkers in Diabetic Patients Presenting with Acute Pulmonary Embolism. Clinical and Applied Thrombosis/Hemostasis. 29. 2995346562–2995346562. 4 indexed citations

Bansal, Vinod, et al.. (2023). The Relevance of Thrombo-Inflammatory Biomarkers and Their Relationship with Circulating Glycosaminoglycans in End-Stage Renal Disease Patients. Clinical and Applied Thrombosis/Hemostasis. 29. 2995351016–2995351016. 3 indexed citations

Siddiqui, Fakiha, Debra Hoppensteadt, Vinod Bansal, et al.. (2022). Endogenous Glycosaminoglycans in Various Pathologic Plasma Samples as Measured by a Fluorescent Quenching Method. Clinical and Applied Thrombosis/Hemostasis. 28. 2985325551–2985325551. 3 indexed citations

Darki, Amir, Fakiha Siddiqui, Debra Hoppensteadt, et al.. (2022). The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients. Clinical and Applied Thrombosis/Hemostasis. 28. 2985273274–2985273274. 3 indexed citations

10.

Murata, Stephen, et al.. (2021). Elevated salivary cortisol predicts response to adjunctive immune modulation in treatment-resistant bipolar depression. Journal of Affective Disorders Reports. 4. 100117–100117. 3 indexed citations

11.

Iqbal, Omer, Fakiha Siddiqui, Nusrat Jabeen, et al.. (2021). Public Perceptions of Current COVID-19 Vaccinations. Results of a Pilot Survey. Clinical and Applied Thrombosis/Hemostasis. 27. 2975248446–2975248446. 3 indexed citations

12.

Poredoš, Pavel, Peter Poredoš, Mateja K. Ježovnik, et al.. (2021). Interrelationship of MMP-9, Proteoglycan-4, and Inflammation in Osteoarthritis Patients Undergoing Total Hip Arthroplasty. Clinical and Applied Thrombosis/Hemostasis. 27. 2875394097–2875394097. 19 indexed citations

13.

Iqbal, Omer, Jeanine M. Walenga, Bruce Lewis, et al.. (2021). An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination. Clinical and Applied Thrombosis/Hemostasis. 27. 2975203002–2975203002. 33 indexed citations

14.

Masic, Dalila, et al.. (2020). Impact of Pulmonary Embolism Response Team on Anticoagulation Prescribing Patterns in Patients With Acute Pulmonary Embolism. Journal of Pharmacy Practice. 35(1). 38–43. 3 indexed citations

15.

Brailovsky, Yevgeniy, et al.. (2020). Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict All-Cause Mortality in Acute Pulmonary Embolism. Clinical and Applied Thrombosis/Hemostasis. 26. 2873299077–2873299077. 54 indexed citations

16.

Jeske, Walter, et al.. (2019). Urinary Prothrombin Fragment 1 + 2 as an Endogenous Marker of Venous Thromboembolism. 4(2). 1 indexed citations

17.

Ouyang, Yilan, Meng Zhu, Xin Wang, et al.. (2019). Systematic analysis of enoxaparins from different sources with online one- and two-dimensional chromatography. The Analyst. 144(12). 3746–3755. 9 indexed citations

18.

Xu, Yongmei, Kasemsiri Chandarajoti, Xing Zhang, et al.. (2017). Synthetic oligosaccharides can replace animal-sourced low–molecular weight heparins. Science Translational Medicine. 9(406). 87 indexed citations

19.

Deitcher, Steven R., Craig M. Kessler, Geno J. Merli, et al.. (2006). Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period. Clinical and Applied Thrombosis/Hemostasis. 12(4). 389–396. 294 indexed citations

20.

Rosenthal, Mark, Danny Rischin, Grant A. McArthur, et al.. (2002). Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia. Annals of Oncology. 13(5). 770–776. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact